{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:12:14Z","timestamp":1784941934272,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01257","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T06:33:21Z","timestamp":1593498801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development"],"prefix":"10.3389","volume":"11","author":[{"given":"Eyal","family":"Grunebaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Leon-Ponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Chapdelaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","article-title":"Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies","volume":"13","author":"Grunebaum","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1084\/jem.191.12.2197","article-title":"Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice","volume":"191","author":"Arpaia","year":"2000","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0889-8561(05)70139-9","article-title":"Immunodeficiency caused by purine nucleoside phosphorylase deficiency","volume":"20","author":"Cohen","year":"2000","journal-title":"Immunol Allergy Clinics North Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1203\/01.PDR.0000111286.23110.F8","article-title":"Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology","volume":"55","author":"Dror","year":"2004","journal-title":"Pediatr Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2307\/3579885","article-title":"Defective modulation of double-strand break repair in ataxia telangiectasia cells by gamma radiation","volume":"150","author":"Sikpi","year":"1998","journal-title":"Radiat Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S0140-6736(75)91950-9","article-title":"Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity","volume":"1","author":"Giblett","year":"1975","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12026-012-8380-9","article-title":"Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency","volume":"56","author":"Somech","year":"2013","journal-title":"Immunol Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00043426-200201000-00018","article-title":"Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency","volume":"24","author":"Baguette","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/15513815.2016.1139020","article-title":"The first report of a pregnancy in a patient with purine nucleoside phosphorylase deficiency","volume":"35","author":"Martin","year":"2016","journal-title":"Fetal Pediatr Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0002-9343(79)90100-1","article-title":"Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency","volume":"67","author":"Rich","year":"1979","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/adc.56.7.563","article-title":"Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder","volume":"56","author":"Watson","year":"1981","journal-title":"Arch Dis Child"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/8904_2015_444","article-title":"Novel genetic mutations in the first Swedish patient with purine nucleoside phosphorylase deficiency and clinical outcome after hematopoietic stem cell transplantation with HLA-matched unrelated donor","volume":"24","author":"Brodszki","year":"2015","journal-title":"JIMD Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nbd.2012.04.001","article-title":"Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice","volume":"47","author":"Mansouri","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clinbiochem.2007.11.007","article-title":"Novel mutations of NP in two patients with purine nucleoside phosphorylase deficiency","volume":"41","author":"Parvaneh","year":"2008","journal-title":"Clin Biochem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00431-009-1029-6","article-title":"Purine nucleoside phosphorylase deficiency with fatal course in two sisters","volume":"169","author":"Aytekin","year":"2010","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/aian.AIAN_430_17","article-title":"Immunodeficiency, motor delay, and hypouricemia caused by a novel mutation of purine nucleoside phosphorylase gene in an Indian infant","volume":"22","author":"Shah","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0022-3476(96)70285-8","article-title":"Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling","volume":"128","author":"Broome","year":"1996","journal-title":"J Pediatr"},{"key":"B18","first-page":"121","article-title":"Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation","volume":"17","author":"Carpenter","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jpeds.2004.06.075","article-title":"Purine nucleoside phosphorylase deficiency presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation","volume":"145","author":"Myers","year":"2004","journal-title":"J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1399-3046.2007.00772.x","article-title":"Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency","volume":"11","author":"Delicou","year":"2007","journal-title":"Pediatr Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fped.2017.00143","article-title":"Infusion of sibling marrow in a patient with purine nucleoside phosphorylase deficiency leads to split mixed donor chimerism and normal immunity","volume":"5","author":"Yeates","year":"2017","journal-title":"Front Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","article-title":"Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications","volume":"109","author":"H\u00f6nig","year":"2007","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fimmu.2016.00314","article-title":"Adenosine deaminase deficiency - more than just an immunodeficiency","volume":"7","author":"Whitmore","year":"2016","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1172\/JCI25052","article-title":"TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice","volume":"116","author":"Toro","year":"2006","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jgm.1261","article-title":"Lentivirus gene therapy for purine nucleoside phosphorylase deficiency","volume":"10","author":"Liao","year":"2008","journal-title":"J Gene Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jama.295.5.508","article-title":"Bone marrow transplantation for severe combined immune deficiency","volume":"295","author":"Grunebaum","year":"2006","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1203\/00006450-198702000-00006","article-title":"A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics","volume":"21","author":"Rijksen","year":"1987","journal-title":"Pediatr Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0022-1759(01)00565-8","article-title":"Cell surface phenotyping and cytokine production f Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs)","volume":"264","author":"Wroblewski","year":"2002","journal-title":"J Immunol Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14785\/lpsn-2014-0024","article-title":"Tandem mass spectrometric determination of purine metabolites and adenosine deaminase activity for newborn screening of ADA\u2013SCID","volume":"2","author":"Al-Dirbashi","year":"2015","journal-title":"LymphoSign J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cellimm.2006.07.003","article-title":"Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro","volume":"240","author":"Toro","year":"2006","journal-title":"Cell Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1034\/j.1399-0004.2001.590608.x","article-title":"Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient","volume":"59","author":"Dalal","year":"2001","journal-title":"Clin Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1067\/mpd.2002.123879","article-title":"Early diagnosis of ataxia telangiectasia using radiosensitivity testing","volume":"140","author":"Sun","year":"2002","journal-title":"J Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/15257770.2011.630852","article-title":"Purine nucleoside phosphorylase deficiency: a mutation update","volume":"30","author":"Walker","year":"2011","journal-title":"Nucleo Nucleot Nucl Acids"},{"key":"B34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clim.2005.03.020","article-title":"Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults\u2013a monocentric German study","volume":"116","author":"Jentsch-Ullrich","year":"2005","journal-title":"Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/08820139.2019.1570249","article-title":"The first purine nucleoside phosphorylase deficiency patient resembling IgA deficiency and a review of the literature","volume":"48","author":"Fekrvand","year":"2019","journal-title":"Immunol Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1111\/petr.12413","article-title":"A successful unrelated peripheral blood stem cell transplantation with reduced intensity-conditioning regimen in a patient with late-onset purine nucleoside phosphorylase deficiency","volume":"19","author":"Celmeli","year":"2015","journal-title":"Pediatr Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/clinchem\/42.6.985a","article-title":"Marked hypouricemia in purine nucleoside phosphorylase deficiency\u2013serendipitous finding on screen","volume":"42","author":"Timms","year":"1996","journal-title":"Clin Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1182\/blood.V97.9.2772","article-title":"Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome","volume":"97","author":"Corneo","year":"2001","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jim.2009.07.008","article-title":"EdU incorporation is an alternative non-radioactive assay to [(3)H]thymidine uptake for in vitro measurement of mice T-cell proliferations","volume":"350","author":"Yu","year":"2009","journal-title":"J Immunol Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF00917017","article-title":"Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients","volume":"7","author":"Markert","year":"1987","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1073\/pnas.0913439107","article-title":"Four generations of transition-state analogues for human purine nucleoside phosphorylase","volume":"107","author":"Ho","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1053\/j.seminoncol.2007.11.004","article-title":"Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies","volume":"5","author":"Furman","year":"2007","journal-title":"Semin Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"11725","DOI":"10.1021\/bi961969w","article-title":"Purine nucleoside phosphorylase. 1. Structure-function studies","volume":"36","author":"Erion","year":"1997","journal-title":"Biochemistry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"11735","DOI":"10.1021\/bi961970v","article-title":"Purine nucleoside phosphorylase. 2. Catalytic mechanism","volume":"36","author":"Erion","year":"1997","journal-title":"Biochemistry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T06:33:23Z","timestamp":1593498803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2020.01257"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01257","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"article-number":"1257"}}